2015 American Transplant Congress Archives - Page 141 of 170

Role of Innate Immune Cells in Chronic Allograft Loss and Novel Strategies to Target Them

C. Wu,^1,2 P. Zhao,¹ W. Liu,¹ X. Xiao,¹ X. Shi,¹ Y. Peng,¹ M. Kloc,¹ X. He,² M. Ghobrial,¹ X. Li.¹
Role of Universal Decolonization After Kidney Transplant: A Pilot Study

D. Lee,¹ G. Malat,² N. Law,¹ A. Sharma,¹ T. Bias,¹ K. Ranganna,¹ A. Doyle.¹
Safer and More Effective Treatment of Acute Postoperative Pain in Living Liver Donors

D. Ladner,¹ R. Fisher,² J. Guarrera,³ E. Pomfret,⁴ M. Simpson,⁴ A. Daud,⁵ T. Curtis,⁵ E. Reyes,⁵ A. Skaro,¹ D. Woods.⁵
Safety and Efficacy of 3-Month Ciprofloxacin for BK Prophylaxis in Kidney Transplantation

S. Patel, R. Knight, J. Loucks, S. Kuten, A. Gaber.
Safety and Efficacy of All Oral DAA Therapy for Genotype 1 HCV Post-Liver Transplant: Interval Results from the HCV-TARGET Multicenter Prospective Observational Study

J. O'Leary,¹ R. Brown,² K. Reddy,³ A. Kuo,⁴ G. Morelli,⁵ R. Stravitz,⁶ G. Everson,⁷ C. Durand,⁸ H. Vargas,⁹ P. Kwo,¹⁰ C. Frenette,¹¹ J. Peter,¹² M. Vainorius,¹² L. Akushevich,¹² D. Nelson,⁵ M. Fried,¹² N. Terrault.¹³
Safety and Efficacy of Conversion from Conventional Twice Daily Tacrolimus to Once Daily Extended Release Tacrolimus in Stable Pancreas Transplant (SPK and PAK) Recipients

M. Dib, A. Barbas, M. Marquez, J. Laurence, G. Sapisochin, A. Norgate, J. Schiff, I. McGilvray, P. Greig, M. Selzner, M. Cattral.
Safety and Efficacy of Early Everolimus in De Novo Orthotopic Liver Transplantation

M. Gastaca,¹ I. Bilbao,² M. Jimenez,³ J. Bustamente,¹ C. Dopazo,² R. Gonzalez,³ R. Charco,² J. Santoyo,⁴ J. Ortiz de Urbina.¹
Safety and Efficacy of Low Dose and Very Low Dose Extended-Release Tacrolimus / MMF in De Novo Kidney Transplant Recipients

Y. Watarai,¹ M. Okada,¹ K. Futamura,¹ K. Ito,¹ T. Yamamoto,¹ M. Tsujita,¹ T. Hiramitsu,¹ N. Goto,¹ S. Narumi,¹ T. Kobayashi.²
Safety and Efficacy of Pegylated Interferon and Ribavirin for Chronic Hepatitis C Following Renal Transplantation

G. Chen, L. Zhu, S. Chen, X. Wang, Z. Lin.
Safety and Outcome of Ganciclovir-Resistant CMV Treated With Foscarnet: A Single Center Retrospective Study

B. Pierce,⁴ C. Richardson,⁴ K. Cunningham,⁴ C. D'Agostino,⁴ C. Tseng,⁴ J. Brown,⁴ C. O'Brien,⁴ B. Ho,^1,3,5 M. Ison.^1,2,3